5.720USD+2.32%Mkt Cap: 25.46M USDP/E: —Last update: 2026-05-26
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offer…
Industry Peers
Medical Instruments & SuppliesIndicators:|
Key Statistics
Company
Market Cap25.46M USD
Enterprise Value53.80M USD
Revenue (TTM)85.53M USD
Gross Profit49.91M USD
Net Income (TTM)-56.70M USD
Revenue/Share19.20 USD
Last Price5.720 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees316
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS4169061052
Valuation
P/E (Trailing)—
P/E (Forward)12.55
PEG1.31
EV/EBITDA6.88
EV/Revenue0.63
P/S0.29
P/B2.46
EPS (TTM)-2.15
EPS (Forward)0.44
52W Range
2.80044% of range9.500
52W High9.500 USD
52W Low2.800 USD
Profitability
Gross Margin57.67%
Oper. Margin-5.66%
EBITDA Margin9.14%
Profit Margin-65.51%
ROE-412.84%
ROA-70.81%
Growth
Revenue Growth-4.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF6.73M USD
CapEx (TTM)1.86M USD
FCF Margin11.27%
FCF Yield37.86%
Net Debt29.11M USD
Net Debt/EBITDA3.72
Balance Sheet
Debt/Equity3.22
Current Ratio1.99
Quick Ratio0.91
Book Value/Sh2.246 USD
Cash/Share1.587 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMar 16, 2026
Analyst Consensus
Rating2.5 (Hold)
Target (Mean)6.000 USD
Target Range6.000 USD – 6.000 USD
# Analysts1
Ownership
Shares Out.4.51M
Float3.50M
Insiders7.65%
Institutions45.91%
Short Interest
Short Ratio2.5d
Short % Float3.85%
Short % Out.3.79%
Shares Short170.73K
Short (prev mo.)84.76K
Technical
SMA 505.672 (+0.8%)
SMA 2005.601 (+2.1%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)41.30K
Avg Vol (10d)30.99K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—